Preparation of 9-nitrocamptothecin self-emulsification microemulsion and in vitro cytotoxicity evaluation

Chinese Journal of New Drugs

Volumn 17, Issue 10, 2008, Pages 861-865

  Lü, Juan Li ^a,b   Liu, Zhen Hua ^b   Wang, Jian Cheng ^a   Zhang, Qiang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b GENERAL HOSPITAL OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

Author keywords

9 nitrocamptothecin; self microemulsifying drug delivery system; cytotoxicity

Indexed keywords

ALCOHOL; EMULSIFYING AGENT; MACROGOL 400; OLEIC ACID ETHYL ESTER; POLYSORBATE 80; RUBITECAN; SULFORHODAMINE B;

ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CANCER CELL CULTURE; CELL STRAIN MCF 7; CELL STRAIN MDA MB 231; CELL STRAIN SH5Y; CELL STRAIN SKOV3; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUTION; DRUG STABILITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MICROEMULSION; PRECIPITATION; SUSPENSION;

EID: 70049110421     PISSN: 10033734     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. CLARK JW. Rubitecan [J]. Expert Opin Investig Drugs ,2006 ,15 (1) :71-79.
2. PUNT CJ,DE JONGE MJ, MONFARDINI S,et al. RFS2000 (9-nitrocamptothecin) in advanced small cell lung cancer, a phase II study of the EORTC New Drug Development Group [J]. Eur J Cancer,2004,40(9) :1332-1334.
3. MICHAELSON MD, RYAN DP, FUCHS CS, et al. A Phase I study of 9-nitrocamptothecin given concurrently with capecitabine in patients with refractory,metastatic solid tumors[J]. Cancer,2003 ,97 (1) :148-154.
4. HUNG CL,DONIGER J.PALINI A,et al. 9-Nitrocamptothecin inhibits HIV-1 replication in human peripheral blood lymphocytes: a potential alternative for HIV-infection/AIDS therapy [j]. J Med Virol,2001,64(3) :238-244.
5. KNIGHT V, KOSHKINA NV, WALDREP JC, et al. Anticancer effect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice[J]. Cancer Chemother Pharmacol, 1999, 44(3) :177-186.
6. POUTON CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ' self-microemulsifying ' drug delivery systems [J]. Eur J Pharm Sci, 2000,11 ( Suppl 2) : S93-S98.